Fever and Rash

Published on 05/03/2015 by admin

Filed under Dermatology

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 4 (1 votes)

This article have been viewed 5568 times

3

Fever and Rash

A variety of infectious and inflammatory conditions can present with fever and a rash (Fig. 3.1). The cutaneous findings range from a morbilliform eruption or urticaria (Figs. 3.2 and 3.3) to confluent erythema (Fig. 3.4) to petechial, vesiculobullous, and pustular lesions (Figs. 3.53.9).

Clinical features that differentiate among entities in the differential diagnosis of an exanthematous drug eruption are summarized in Fig. 3.10.

imageimage

Fig. 3.10 Approach to the patient with a suspected drug-induced exanthem (morbilliform, urticarial). With a few exceptions (e.g., pityriasis rosea, drug-induced autoimmune bullous disorders), patients with these entities may be febrile. Entities in italics occur primarily in children. Toxic shock syndrome can be staphylococcal or streptococcal (see Ch. 61). Acute generalized exanthematous pustulosis (AGEP) is also referred to as a pustular drug eruption. Drug-induced autoimmune bullous disorders: bullous pemphigoid or linear IgA bullous dermatosis > drug-induced pemphigus.

Although the initial skin findings of some potentially life-threatening disorders can mimic a more common benign disorder, the development of other cutaneous and extracutaneous features as the condition evolves points to the correct diagnosis (Table 3.1).

Kawasaki Disease

Acute febrile multisystem vasculitic syndrome that primarily affects children <5 years of age (rarely adults), with ~3-fold higher incidence in Asians than Caucasians.

Most common cause of pediatric acquired heart disease in the United States, with greatest morbidity from coronary artery aneurysms.

Etiology remains unknown; factors include a genetic predisposition to immune activation and possibly an infectious trigger.

Diagnostic criteria include fever (>39°C/102°F) for ≥5 days plus the presence of ≥4 of the following five criteria.

Bilateral nonpurulent bulbar conjunctival injection.

Oropharyngeal changes such as ‘chapped’/fissured lips (Fig. 3.11), a ‘strawberry’ tongue, and diffuse hyperemia.

Cervical lymphadenopathy (>1.5 cm; usually unilateral).

Erythema, edema, and (eventually) desquamation of the hands and feet (Fig. 3.12A).

Polymorphous exanthem – morbilliform or urticarial > erythema multiforme-like (Fig. 3.12B), scarlatiniform, or pustular.

Initial manifestation is often erythema in the perineal area, followed by desquamation (Fig. 3.12B–3.12D).

‘Incomplete’ Kawasaki disease (more common in infants) is diagnosed if fever for ≥5 days and coronary artery abnormalities (via echocardiography or angiography) but <4 other criteria.

Other cardiac (e.g., myo-/pericarditis, valvular abnormalities), CNS (e.g., irritability, aseptic meningitis), musculoskeletal (e.g., arthritis), gastrointestinal, and genitourinary involvement can occur.

Laboratory findings of acute disease include leukocytosis with neutrophilia, anemia, elevated ESR/CRP and hepatic transaminase levels, hypoalbuminemia and sterile pyuria; thrombocytosis typically develops by the 2nd or 3rd week (occasionally thrombocytopenia early).

DDx: viral exanthem, scarlet fever, toxic shock syndrome, early staphylococcal scalded skin syndrome, drug reaction, erythema multiforme, Still’s disease, periodic fever syndrome.

Rx: IVIg and aspirin are first-line; corticosteroids and infliximab are options for refractory disease.